Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings
Markets & Money Today | 2 Min News | The Daily News Now! - Podcast autorstwa The Daily News Now! - Czwartki
Kategorie:
Eli Lilly's Q3 profit surges due to soaring demand for weight-loss drugs Mounjaro and Zepbound, driving a 54% revenue increase and sending shares up 5%. The company is now a major player in the weight-loss drug market, with plans to launch a new pill and partner with Nvidia for AI-powered innovation.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.
